pargyline has been researched along with Hypertension, Renal in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Hypertension, Renal: Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeQuattro, V | 1 |
Miura, Y | 1 |
Fröhling, P | 1 |
Lemke, E | 1 |
Lindenau, K | 1 |
Behla, M | 1 |
Nestor, G | 1 |
Beroniade, V | 1 |
Tutunaru, M | 1 |
3 other studies available for pargyline and Hypertension, Renal
Article | Year |
---|---|
Neurogenic factors in human hypertension: mechanism or myth?
Topics: Angiotensin II; Blood Pressure; Catecholamines; Chemical Phenomena; Chemistry; Dihydroxyphenylalanin | 1973 |
[Long-term therapy of renal hypertension with various antihypertensive combinations in nephrologic dispensary consultations].
Topics: Drug Combinations; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Imidazoles; Long-Term Car | 1973 |
[Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
Topics: Adult; Antihypertensive Agents; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidn | 1970 |